About Us

Greeting from President

On Assuming the Position of President of the Japan Society of Gynecologic Oncology

I am Nao Suzuki, and I have recently been appointed as President of the Japan Society of Gynecologic Oncology (JSGO). I am fully committed to devoting all my energy to serving our members and to protecting the health and future of women in Japan and around the world.

The field of obstetrics and gynecology encompasses specialized areas such as perinatal medicine, reproductive medicine, women’s health, and gynecologic oncology, which deals with tumors of the uterus, ovaries, and other female reproductive organs. Within this field, our Society is an academic organization dedicated specifically to the prevention, diagnosis, and treatment of malignant gynecologic tumors. Bringing together experts from multiple disciplines—including not only obstetricians and gynecologists but also pathologists, radiologists, and medical oncologists—we aim to protect patients’ dignity and create an environment where they can continue to thrive in society as their true selves even after treatment.

Our Society traces its origins to the Japan Colposcopy Study Group established in 1975. After transitioning to an NPO and then a public interest incorporated association, it was approved as an affiliate society of the Japanese Association of Medical Sciences in 2021. Our Society has led the field of gynecologic cancer care in Japan, focusing on the following key initiatives:

Development and revision of clinical practice guidelines (standardization and advancement of medical care)
Organization of academic conferences and seminars (professional development and continuing education)
Administration of the Gynecologic Oncology Specialist Certification Program (providing high-quality multidisciplinary care)
Publication of an English-language journal and research grants (advancing scholarship and strengthening clinical research)
Collaboration with related societies in Japan and abroad (international cooperation and sharing of the latest information)

It is both a great source of pride and a significant responsibility to carry on the solid foundation established by past presidents, including former President Aikou Okamoto. We are committed to further development as we move toward the next era. In recent years, the field of gynecologic oncology has entered a period of major transformation, marked by the rise of cancer genomics, immunotherapy, minimally invasive surgery, and advancements in AI and data science. To respond to these rapid changes and ensure the Society’s sustainable development, we intend to breathe new life into the organization by working alongside our young and mid-career members—the leaders of the next generation. We will actively embrace fresh perspectives and flexible thinking as we move forward, guided by the following “Six Pillars.”

1. Promoting a “Society Connected to the World Through Two-Way Communication”

We will further accelerate our internationalization efforts. In November 2027, we will co-host the “IGCS (International Gynecologic Cancer Society) and the 69th Annual Scientific Meeting” in Tokyo. We will minimize language and participation barriers as much as possible to create a forum where all members—especially young and mid-career physicians—can engage in dialogue with the world and share their insights while remaining in Japan. Furthermore, we will create opportunities for learning and exchange where everyone can “connect with the world in both directions.”

2. Reforming the Education System and Board Certification Program for Sustainability

We will advance reforms toward a “modern board certification system” adapted to diverse work styles. We will actively incorporate the perspectives of young and mid-career members into the Society’s operations to achieve a “circulation of knowledge” across generations and a highly transparent decision-making process. Furthermore, in response to the diversification of multidisciplinary treatments and supportive care, we will advance reforms to create a sustainable gynecologic oncology board certification system that is in step with the times. With the dramatic progress in anticancer drug therapy and the growing importance of “living with cancer”—including palliative care, cancer treatment, and reproductive medicine—the board certification system itself is now at a turning point for transformation. We will shift toward an educational system that encompasses not only surgical techniques but also a broader and more diverse range of fields. At the same time, we aim to establish a flexible system that enables physicians—including those who have experienced life events such as childbirth and child-rearing, as well as those working in hospitals facing regional disparities—to sustainably obtain, renew, and maintain their specialist certification.

3. Promotion of Patient and Public Involvement (PPI)

To realize truly “patient-centered care,” we have established a new “Working Group on PPI (Patient and Public Involvement)” to ensure that the voices of those directly affected are heard in the development of clinical guidelines, as well as in research and education. We will work closely with the national government and relevant organizations to strive for the realization of “gynecologic oncology care that supports the lives of all women.”

4. Integration of AI and Digital Healthcare

While promoting personalized medicine, we will establish a framework through the newly formed “Working Group on the Promotion of AI and Digital Healthcare in Gynecologic Oncology” to safely and effectively apply advanced technologies to diagnosis, treatment, and patient support. We will build an advanced system capable of responding promptly to the digital transformation of healthcare and the development of interdisciplinary medicine.

5. Precision Medicine and Cross-Specialty Innovation

Gynecologic oncology is currently undergoing a period of major transformation. We will reorganize the working group into the “Working Group on the Promotion of Precision Medicine” to further advance personalized medicine, and, together with experts from other medical specialties, take the lead in introducing cutting-edge medical care to save patients’ lives.

6. Establishment of a New Organization Where Young and Mid-Career Members Can Take the Lead in Discussing and Proposing Society Management and Future Visions

It is all of you—those currently working tirelessly on the front lines—who will shape the future of gynecologic oncology. The Society must not only be a place to acquire knowledge but also a “stage for challenges” where members can use their own ideas to transform the healthcare system and make their mark on the world. We pledge to build a transparent and vibrant organization where young and mid-career members can engage in lively discussions and have their opinions directly reflected in the Society’s decision-making. Let us pool our wisdom and work together to design the future of the Japan Society of Gynecologic Oncology. We will establish a transparent and dynamic framework where young and mid-career members take the lead in discussing and proposing ideas regarding the Society’s operations and future vision (Career Co-creation Committee: LEAD (Leadership and Early Career Advancement & Development Committee); Next-Generation and Mid-Career Physicians Collaboration Council). Please make full use of this Society as a “stage for challenges” where you can shape the future of healthcare with your own ideas and spread your wings to the world.

All of our Society’s activities are dedicated to realizing a society where women in Japan and around the world can live healthy and happy lives. We sincerely ask for your warm guidance and cooperation.

July, 2026
Japan Society of Gynecologic Oncology
President Nao Suzuki, M.D., Ph.D.